Understanding how Merkel cells regenerate and their role in touch and itch sensations
Cellular and Molecular Mechanisms Underlying Merkel Cell Loss and Regeneration
This study is looking at how our bodies lose and regrow special skin cells called Merkel cells, which help us feel light touch and manage itchiness, especially as we get older or have dry skin, to find new ways to help reduce itchiness for older adults.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10999568 on NIH RePORTER |
What this research studies
This research investigates the cellular and molecular mechanisms that control the loss and regeneration of Merkel cells, which are essential for sensing light touch and regulating itch sensations. The study focuses on how aging and dry skin conditions affect the number of these cells, particularly in older adults. Using mouse models, researchers will explore the regeneration process of Merkel cells and identify the specific progenitor cells responsible for this regeneration. The findings could lead to new therapies aimed at preventing itch sensations associated with aging and skin dryness.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing increased itch sensations and dry skin conditions.
Not a fit: Patients who are younger than 21 or do not experience issues with itch sensations or dry skin may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that alleviate itch sensations in elderly patients suffering from dry skin.
How similar studies have performed: Previous studies have shown promising results in understanding cell regeneration mechanisms, suggesting that this approach could yield valuable insights.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Ezhkova, Elena — Icahn School of Medicine at Mount Sinai
- Study coordinator: Ezhkova, Elena
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.